Payer Perceptions of Health Inequalities in Reimbursement Decision Making: Implications for the Pharmaceutical Industry
Author(s)
Kuldeep Singh, MIH, MBA, Genesis Research Group, Newcastle upon Tyne, England, UK and Tijana Ignjatovic, PhD, Genesis Research Group, Newcastle upon Tyne, England, UK
Presentation Documents
Addressing health inequalities will become more important in future reimbursement and coverage decisions. However, there remains a need for a clear framework to be in place, a better understanding of how to measure inequality, and shared knowledge of how these factors will be considered relative to clinical outcomes. For example, future use of health technology assessment (HTA) tools such as cost-effectiveness may need to factor in unmet need for particular sub-populations of patients.
This HEOR Theater presentation will highlight recent recommendations from the Institute for Clinical and Economic Review (ICER) and from National Institute for Health and Care Excellence (NICE) related to HTA methods and health inequality. Results from a qualitative payer survey on their perceptions of health equity, its current and future role in decision-making will provide direct insight into current stakeholder views on this important issue.
Audience Objectives:
- Understand how health inequality is currently considered in the HTA and payer coverage & reimbursement decisions
- Find out what aspects of health inequality are prioritized by payers and HTAs
- Learn how HTA tools and needs may evolve to decrease health inequality and key challenges in achieving those goals
Conference/Value in Health Info
2024-05, ISPOR 2024, Atlanta, GA, USA
Code
133
Topic
Health Policy & Regulatory